Officials understand that neither company has finalised any changes to their distribution arrangements.
The Department will monitor any new arrangements. If the changes result in shortages, disruptions to supply, any additional costs to the national health service, or has a detrimental affect on funding pharmacy contractors then the Department will seek to ensure the corrective action is taken.